文献
J-GLOBAL ID:202002226671278667
整理番号:20A0368567
HER2過剰発現または変異進行NSCLCにおける[fam-]trastuzumab deruxtecan (DS-8201a)の第2相試験
Phase 2 study of[fam-] trastuzumab deruxtecan (DS-8201a) in HER2-overexpressing or -mutated advanced NSCLC
著者 (11件):
GOTO Yasushi
(National Cancer Center Hospital)
,
NAKAGAWA Kazuhiko
(Kindai Univ. Fac. of Medicine)
,
UDAGAWA Hibiki
(National Cancer Center Hospital East)
,
MURAKAMI Haruyasu
(Shizuoka Cancer Center)
,
FUJIWARA Yutaka
(National Cancer Center Hospital)
,
LI Bob T.
(Memorial Sloan Kettering Cancer Center)
,
PLANCHARD David
(Inst. Gustave Roussy)
,
SHIGA Ryota
(Daiichi Sankyo Co., Ltd.)
,
LEE Caleb
(Daiichi Sankyo, Inc.)
,
WANG Kongming
(Daiichi Sankyo, Inc.)
,
JANNE Pasi A.
(Dana-Farber Cancer Inst. and the Belfer Center for Applied Cancer Sci.)
資料名:
日本臨床腫瘍学会学術集会(CD-ROM)
(Program and Abstracts. Annual Meeting of Japanese Society of Medical Oncology (CD-ROM))
巻:
17th
ページ:
ROMBUNNO.P3-239
発行年:
2019年
JST資料番号:
L7804B
資料種別:
会議録 (C)
記事区分:
会議録記事
発行国:
日本 (JPN)
言語:
英語 (EN)